Sinopharm
1099.HK
#1986
Rank
C$10.57 B
Marketcap
$3.39
Share price
0.76%
Change (1 day)
-4.71%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): C$3.25 Billion

According to Sinopharm's latest financial reports the company's current earnings are C$84.39 Billion. a decrease over its 2022 earnings that were of C$4.55 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 C$4.51 B-0.73%
2022 C$4.55 B-1.72%
2021C$4.63 B11.7%
2020C$4.14 B18.44%
2019C$3.49 B10.85%
2018C$3.15 B3.05%
2017C$3.06 B36.48%
2016C$2.24 B7.11%
2015C$2.09 B12.38%
2014C$1.86 B25.05%
2013C$1.49 B22.54%
2012C$1.21 B35.43%
2011C$0.89 B52.24%
2010C$0.59 B30.99%
2009C$0.45 B60.59%
2008C$0.28 B48.29%
2007C$0.18 B123.29%
2006C$84.75 M